The Nebraska Medical Association

https://www.nebmed.org/

 

Nebraska Oncology Society
G

2020 ASCO Highlights on Advanced CRC: Does mFOLFIRINOX Show DFS Benefit vs. Chemoradiation Among LARC Patients? Is Encorafenib+Cetuximab+/-Binimetinib Effective for BRAF V600E Mutations? What Is the ORR With T-DXd in HER2+ Metastatic Disease?

By Nebraska Oncology Society FEATURING George Kim
By Nebraska Oncology Society FEATURING George Kim
15 views
November 30, 2020
Comments 0
Login to view comments. Click here to Login

Featured Video

21:24
Exelixis

Hypothetical Patient Case: Hepatocellular Carcinoma with Progression…

Feat. J. Gutierrez, J. Strauss

Featured Video

19:38
Exelixis

Hypothetical Patient Case: 1L Advanced Renal Cell Carcinoma and Qual…

Feat. R. Alter, A. Rezazadeh
Nebraska Oncology Society
07:33

Targeted Therapy for mNSCLC: What Is the Response Rate With Selperca…

Nebraska Oncology Society

G. Riely

199 views
15:24

NSCLC Targeted Therapies Update: Should We Consider EGFR Targeted Th…

Nebraska Oncology Society

G. Riely

159 views
09:41

ASCO 2020 Review of Transoral Robotic Surgery for OPC : Is 2-yr PFS …

Nebraska Oncology Society

E. Sherman

13 views
09:24

2020 ASCO LA-HNSCC Trials Review: What Is the Efficacy of Weekly CDD…

Nebraska Oncology Society

E. Sherman

13 views
11:38

ASCO 2020 Update on DO-IMRT & HNC Metastatic: Does Change in IMRT Le…

Nebraska Oncology Society

E. Sherman

20 views
04:56

2020 ASCO Update on Metastatic/Recurrent HNSCC: What Is the Efficacy…

Nebraska Oncology Society

E. Sherman

15 views
08:09

2020 ASCO Update on RET-Altered Thyroid Cancer: What Is the Efficacy…

Nebraska Oncology Society

E. Sherman

25 views
06:13

Nebraska Oncology Society 2020 Update on Advanced UC: Is Atezo Benef…

Nebraska Oncology Society

N. Vogelzang

48 views
17:42

Nebraska Oncology Society 2020 Update on PC: Does 18F-DCFPyL-PET/CT …

Nebraska Oncology Society

N. Vogelzang

118 views
13:26

Nebraska Oncology Society 2020 Update on Advanced RCC: Is 1L Pembro+…

Nebraska Oncology Society

N. Vogelzang

170 views
11:59

2020 ASCO mCRC Updates Recap: Did We Experience Pseudoprogression Wi…

Nebraska Oncology Society

G. Kim

48 views
05:11

2020 ASCO Updates on GI Cancers: Is Chemo w/ mFOLFIRINOX More Effect…

Nebraska Oncology Society

G. Kim

13 views
10:06

2020 ASCO Highlights on Advanced CRC: Does mFOLFIRINOX Show DFS Bene…

Nebraska Oncology Society

G. Kim

15 views
04:13

2020 ASCO Updates on mCRC: Is Adjuvant mFOLFOX Superior to Hepatecto…

Nebraska Oncology Society

G. Kim

25 views
07:52

2020 ASCO Highlights on Stage 3 Colon Cancer: What Are the DFS/OS Di…

Nebraska Oncology Society

G. Kim

21 views
10:48

KEYNOTE-177 2020 ASCO Update on MSI-H/dMMR mCRC: Does Pembro Improve…

Nebraska Oncology Society

G. Kim

28 views
07:39

ES-SCLC 2020 Update: Which IO Options Showed Activity in Phase III T…

Nebraska Oncology Society

G. Riely

93 views
16:08

Stage IV NSCLC 2020 Update: Is There a Benefit to Short-Course Chemo…

Nebraska Oncology Society

G. Riely

122 views
30:39

2020 ASCO Updates on IO in Advanced Melanoma: What Are the Outcomes …

Nebraska Oncology Society

S. Bhatia

65 views
10:23

2020 ASCO Highlights on Neoadjuvant IO in Stage 3 Melanoma: Does Ipi…

Nebraska Oncology Society

S. Bhatia

43 views
21:02

2020 ASCO Updates on Frontline Multiple Myeloma: KRd vs. VRd - What …

Nebraska Oncology Society

A. Cohen

302 views
25:01

2020 ASCO Updates on R/R Myeloma: Does FDA-Approved Selinexor Offer …

Nebraska Oncology Society

A. Cohen

335 views